While bulk tumor analysis represents a limitation of our study, nonetheless we identified significant upregulation of key TSK signature genes, in particular PLAU, MMP1 and MMP10, ITGA5 in MET vs. PRI- and PRI+ vs. PRI-. This evidence concerns the gene MMP10 and neoplasm.